Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAptevo Announces Pricing of $22 Million Offering of Common Stock and WarrantsPREV STORYRoche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions
